| Literature DB >> 32059401 |
Min-Jeong Cheon1, Sung-Min Lim1, Na-Kyoung Lee1, Hyun-Dong Paik1.
Abstract
The purpose of this study was to evaluate the probiotic characteristics and neuroprotective effects of bacteria isolated from Korean fermented foods. Three bacterial strains (Lactobacillus fermentum KU200060, Lactobacillus delbrueckii KU200171, and Lactobacillus buchneri KU200793) showed potential probiotic properties, such as high tolerance against artificial gastric juice and bile salts, sensitivity to antibiotics, nonproduction of carcinogenic enzymes, and high adhesion to intestinal cells. Heat-killed L. fermentum KU200060 and L. buchneri KU200793 showed higher antioxidant activity than heat-killed L. delbrueckii KU200171. The conditioned medium (CM) was used to evaluate the reaction between HT-29 cells and each heat-killed strain. All CMs protected SH-SY5Y cells from 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity. The expression of brain-derived neurotropic factor (BDNF) mRNA in HT-29 cells treated with CM containing heat-killed L. buchneri KU200793 was the highest. The CM significantly reduced the Bax/Bcl-2 ratio and increased BDNF mRNA expression in SH-SY5Y cells treated with MPP+. These results indicate that L. buchneri KU200793 can be used as a prophylactic functional food, having probiotic potential and neuroprotective effects.Entities:
Keywords: Lactobacillus buchneri; gut-brain-axis; kimchi; neuroprotective effect; probiotics
Mesh:
Substances:
Year: 2020 PMID: 32059401 PMCID: PMC7072984 DOI: 10.3390/ijms21041227
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Tolerance of Lactobacillus strains to artificial gastric conditions and its adhesion ability to the HT-29 cell.
| LAB Strains | Survival Rate (%) | Adhesion Ability to HT-29 Cells (%) | |
|---|---|---|---|
| Gastric Acid Tolerance (0.3% Pepsin, pH 2.5) | Bile Salts Tolerance (0.3% Oxgall) | ||
| 99.68 ± 0.26 c (1) | 100.41 ± 0.15 b | 2.34 ± 0.15 b | |
| 100.47 ± 0.07 b | 102.24 ± 0.70 a | 1.18 ± 0.04 c | |
| 62.68 ± 0.12 d | 102.43 ± 0.50 a | 1.83 ± 0.01 bc | |
| 102.12 ± 0.35 a | 91.47 ± 0.46 c | 14.10 ± 0.45 a | |
(1) a–d Different superscript letters in the same row indicate significant differences in each characteristic (p < 0.05). All values are mean ± standard error of triplicate experiments.
Enzyme activities of the Lactobacillus strains measured using the API ZYM kit.
| Enzyme | Enzyme Activity | |||
|---|---|---|---|---|
| Control | 0 (1) | 0 | 0 | 0 |
| Alkaline phosphate | 0 | 0 | 0 | 0 |
| Esterase | 2 | 1 | 0 | 0 |
| Esterase lipase | 1 | 1 | 0 | 0 |
| Lipase | 0 | 0 | 0 | 0 |
| Leucine arylamidase | 3 | 2 | 4 | 3 |
| Valine arylamidase | 3 | 0 | 3 | 2 |
| Cystine arylamidase | 0 | 0 | 0 | 0 |
| Trypsin | 0 | 0 | 0 | 0 |
| α-Chymotrypsin | 0 | 0 | 0 | 0 |
| Acid phosphatase | 1 | 1 | 1 | 0 |
| Naphthol-AS-BI-phosphohydrolase | 2 | 1 | 2 | 1 |
| α-Galactosidase | 0 | 4 | 0 | 0 |
| β-Galactosidase | 0 | 5 | 0 | 4 |
| β-Glucuronidase | 0 | 0 | 0 | 0 |
| α-Glucosidase | 3 | 1 | 0 | 0 |
| β-Glucosidase | 4 | 0 | 0 | 1 |
| 0 | 0 | 0 | 2 | |
| α-Mannosidase | 0 | 0 | 0 | 0 |
| α-Fucosidase | 0 | 0 | 0 | 0 |
(1) 0, 0 nM; 1, 5 nM; 2, 10 nM; 3, 20 nM; 4, 30 nM; and 5, ≥40 nM.
Antibiotic resistances of the Lactobacillus strains.
| Antioxidant Activity | LAB Strains | |||
|---|---|---|---|---|
| Ampicillin | S (1) | S | S | S |
| Gentamicin | R | R | R | R |
| Kanamycin | R | R | R | R |
| Streptomycin | R | R | R | R |
| Tetracycline | S | S | S | S |
| Ciprofloxacin | R | R | R | R |
| Chloramphenicol | S | S | S | S |
| Doxycycline | S | S | S | S |
(1) S, susceptible; I, intermediate; and R, resistant.
Antioxidant activities of the Lactobacillus strains.
| Antioxidant Activity | LAB Strains | |||
|---|---|---|---|---|
| DPPH radical scavenging activity (%) | 23.76 ± 1.53 a (1) | 21.81 ± 1.62 a | 17.20 ± 0.48 b | 23.04 ± 0.88 a |
| ABTS radical scavenging activity (%) | 90.92 ± 1.91 a | 91.87 ± 3.27 a | 68.33 ± 1.91 b | 90.05 ± 3.27 a |
| Inhibition rate of β-carotene and linoleic acid oxidation (%) | 33.63 ± 2.60 ab | 28.49 ± 2.79 b | 16.09 ± 2.13 c | 38.42 ± 3.56 a |
(1) a–c Different superscript letters in the same row indicate significant differences in each characteristic (p < 0.05). All values are the mean ± standard error of triplicate experiments.
Figure 1Neuroprotective effect of conditioned medium (CM) on MPP+ (1 mM)-stressed SH-SY5Y cells. L. rhamnosus GG, CM of heat-killed L. rhamnosus GG; L. fermentum 200060, CM of heat-killed L. fermentum KU200060; L. delbrueckii 200171, CM of heat-killed L. delbrueckii KU200171; and L. buchneri 200793, CM of heat-killed L. buchneri KU200793. All values are expressed as mean ± standard error of triplicate experiments. Different superscript letters on each bar represent significant differences (p < 0.05).
Figure 2mRNA expression levels of the brain-derived neurotropic factor (BDNF) gene in heat-killed lactic acid bacteria (LAB) treated HT-29 cells using RT-PCR. The fold change was calculated based on normalization with GAPDH gene expression. Control group was treated with PBS. L. rhamnosus GG, heat-killed L. rhamnosus GG; L. fermentum 200060, heat-killed L. fermentum KU200060; L. delbrueckii 200171, heat-killed L. delbrueckii KU200171; and L. buchneri 200793, heat-killed L. buchneri KU200793. All values are expressed as mean ± standard error of triplicate experiments. Different superscript letters on each bar represent significant differences (p < 0.05).
Figure 3mRNA expression of (A) BDNF and (B) apoptosis-related genes (Bax/Bcl-2 ratio) in SH-SY5Y cells using RT-PCR. L. rhamnosus GG, CM of heat-killed L. rhamnosus GG; L. fermentum 200060, CM of heat-killed L. fermentum KU200060; L. delbrueckii 200171, CM of heat-killed L. delbrueckii KU200171; and L. buchneri 200793, CM of heat-killed L. buchneri KU200793. All values are mean ± standard error of triplicate experiments. Different superscript letters on each bar represent significant differences (p < 0.05).
Primer sequences related to the neuroprotective effect used in real-time PCR.
| Primer (1) | Sequence (5′-3′) | Reference |
|---|---|---|
| BDNF | (sense) CAAACATCCGAGGACAAGGTGG | [ |
| (antisense) CTCATGGACATGTTTGCAGCATCT | ||
| Bax | (sense) GTGGTTGCCCTCTTCTACTTTGC | |
| (antisense) GAGGACTCCAGCCACAAAGATG | ||
| Bcl-2 | (sense) CGGCTGAAGTCTCCATTAGC | |
| (antisense) CCAGGGAAGTTCTGGTGTGT | ||
| GAPDH | (sense) GAGTCAACGGATTTGGTCGT | |
| (antisense) GACAAGCTTCCCGTTCTCAG |
(1) BDNF, brain-derived neurotrophic factor; Bax, bcl-2-associated X protein; Bcl-2, B-cell lymphoma; and GAPDH, glyceraldehyde-3-phosphate dehydrogenase.